LU78259A1 - - Google Patents

Info

Publication number
LU78259A1
LU78259A1 LU78259A LU78259A LU78259A1 LU 78259 A1 LU78259 A1 LU 78259A1 LU 78259 A LU78259 A LU 78259A LU 78259 A LU78259 A LU 78259A LU 78259 A1 LU78259 A1 LU 78259A1
Authority
LU
Luxembourg
Application number
LU78259A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB41483/76A external-priority patent/GB1548022A/en
Application filed filed Critical
Publication of LU78259A1 publication Critical patent/LU78259A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU78259A 1976-10-06 1977-10-05 LU78259A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB41483/76A GB1548022A (en) 1976-10-06 1976-10-06 Pharmaceutial dosage forms
GB3039977 1977-07-20

Publications (1)

Publication Number Publication Date
LU78259A1 true LU78259A1 (cg-RX-API-DMAC7.html) 1978-06-09

Family

ID=26260429

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78259A LU78259A1 (cg-RX-API-DMAC7.html) 1976-10-06 1977-10-05

Country Status (12)

Country Link
JP (1) JPS5344619A (cg-RX-API-DMAC7.html)
AU (1) AU513845B2 (cg-RX-API-DMAC7.html)
CH (1) CH633717A5 (cg-RX-API-DMAC7.html)
CY (1) CY1129A (cg-RX-API-DMAC7.html)
DE (1) DE2744493A1 (cg-RX-API-DMAC7.html)
FR (1) FR2366835A1 (cg-RX-API-DMAC7.html)
HK (1) HK58081A (cg-RX-API-DMAC7.html)
IE (1) IE45770B1 (cg-RX-API-DMAC7.html)
KE (1) KE3171A (cg-RX-API-DMAC7.html)
LU (1) LU78259A1 (cg-RX-API-DMAC7.html)
MY (1) MY8200187A (cg-RX-API-DMAC7.html)
NL (1) NL189898C (cg-RX-API-DMAC7.html)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455459A1 (fr) * 1979-05-02 1980-11-28 Sertog Procede d'obtention d'une matrice contenant un principe actif et le liberant progressivement
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
AT385200B (de) * 1986-07-22 1988-02-25 Kwizda Fa F Johann Verfahren zur herstellung von tabletten mit retardierter freisetzungscharakteristik von arzneistoffen
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
JPH02247447A (ja) * 1989-03-17 1990-10-03 Matsushita Refrig Co Ltd 空気調和機の制御装置
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
JPH0331644A (ja) * 1989-06-28 1991-02-12 Matsushita Refrig Co Ltd 空気調和機の制御装置
FR2657258A1 (fr) 1990-01-19 1991-07-26 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
JP2614409B2 (ja) * 1991-12-20 1997-05-28 ファイザー・インコーポレーテッド 多孔質の付形された放出製剤およびその製造方法
FI943042A0 (fi) 1991-12-24 1994-06-23 Yamanouchi Pharma Co Ltd Suuontelossa hajoava valmiste ja sen valmistus
DE4221880A1 (de) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
CA2182981C (en) * 1994-03-02 2006-10-17 Leonardus Petrus Carla Delbressine Sublingual or buccal pharmaceutical composition
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US20010014340A1 (en) 1996-06-14 2001-08-16 Motohiro Ohta Intrabuccally rapidly disintegrating tablet
GB9717770D0 (en) * 1997-08-21 1997-10-29 Scherer Ltd R P Pharmaceutical composition
ES2175799T3 (es) * 1997-10-08 2002-11-16 Sepracor Inc Forma de dosificacion para administracion en aerosol.
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
GB9722682D0 (en) * 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP4173670B2 (ja) * 2002-03-08 2008-10-29 旭化成ファーマ株式会社 口腔内崩壊製剤
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
WO2004075875A1 (en) * 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20080031944A1 (en) * 2006-08-04 2008-02-07 Cima Labs Inc. Stabilization of lorazepam
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
JP6572257B2 (ja) * 2017-05-16 2019-09-04 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB836811A (en) * 1955-07-08 1960-06-09 Ciba Ltd Shaped medicament carriers and process for their manufacture
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten

Also Published As

Publication number Publication date
IE45770B1 (en) 1982-11-17
DE2744493C2 (cg-RX-API-DMAC7.html) 1991-07-18
NL7710876A (nl) 1978-04-10
JPS6250445B2 (cg-RX-API-DMAC7.html) 1987-10-24
AU2882577A (en) 1979-03-22
DE2744493A1 (de) 1978-04-13
NL189898B (nl) 1993-04-01
CH633717A5 (en) 1982-12-31
HK58081A (en) 1981-12-04
IE45770L (en) 1978-04-06
AU513845B2 (en) 1981-01-08
KE3171A (en) 1981-12-18
CY1129A (en) 1982-02-19
NL189898C (nl) 1993-09-01
FR2366835B1 (cg-RX-API-DMAC7.html) 1980-10-24
FR2366835A1 (fr) 1978-05-05
JPS5344619A (en) 1978-04-21
MY8200187A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
FR2366835B1 (cg-RX-API-DMAC7.html)
CH634453GA3 (cg-RX-API-DMAC7.html)
FI771410A7 (cg-RX-API-DMAC7.html)
JPS5610586Y2 (cg-RX-API-DMAC7.html)
JPS52104407U (cg-RX-API-DMAC7.html)
JPS5732331Y2 (cg-RX-API-DMAC7.html)
JPS5734452B2 (cg-RX-API-DMAC7.html)
CS177443B1 (cg-RX-API-DMAC7.html)
JPS52103647U (cg-RX-API-DMAC7.html)
JPS52148140U (cg-RX-API-DMAC7.html)
JPS5383401U (cg-RX-API-DMAC7.html)
JPS52113267U (cg-RX-API-DMAC7.html)
JPS52122656U (cg-RX-API-DMAC7.html)
JPS52144883U (cg-RX-API-DMAC7.html)
JPS5377125U (cg-RX-API-DMAC7.html)
CS175515B1 (cg-RX-API-DMAC7.html)
JPS52169717U (cg-RX-API-DMAC7.html)
DD126827A1 (cg-RX-API-DMAC7.html)
DD125507A3 (cg-RX-API-DMAC7.html)
DD127203A1 (cg-RX-API-DMAC7.html)
DD127109A1 (cg-RX-API-DMAC7.html)
DD126984A3 (cg-RX-API-DMAC7.html)
DD126874A1 (cg-RX-API-DMAC7.html)
DD126834A1 (cg-RX-API-DMAC7.html)
DD127355A1 (cg-RX-API-DMAC7.html)